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Abstract-Brain cortices or bulk-isolated neuronal cell bodies prepared from cortices of 8-day old 
male rats were used as the source of a I-methyl adenine-specific tRNA methyltransferase (tRNA-AMT). 
Ammonium sulfate fractionation and chromatography on spheroidal hydroxylapatite and Sephadex 
(3-200 yielded an 80-fold purified enzyme, as determined by using E. coli bulk tRNA as substrate. 
The kinetic parameters of tRNA-AMT for the substrate S-adenosyl-L-methionine (SAM) ( K ,  = 6 PM) 
and the inhibitor, S-adenosyl-L-homocysteine (SAH) (Ki = 3.4 PM) were determined and several SAH 
analogs tested as inhibitors. S-Adenosyl-L-cysteine (SAC) ( 1 0 - 4 ~ )  and S-adenosyl-o-homocysteine 
(SADH) ( I W 4 ~ )  produced a 35 and a 21% reduction in enzyme activity, respectively. The effects 
of Mg", NH; acetate and of the polyamines spermine, putrescine and spermidine on the brain tRNA- 
AMT mimicked the effects of these agents on hepatic tRNA-AMT (GLICK et al., 1975). 
Comparing the ability of cerebral tRNA-AMT to methylate E. coli tRNAE'"', tRNA'"', tRNAPh' 
and bulk tRNA revealed tRNAgIu2 as the best and tRNAph' as the least effective substrate. 
tRNA-AMT prepared from neuronal cell bodies showed closely similar characteristics to the cortical 
enzyme. A comparison of the activities of tRNA-AMT in neurons and glial cells revealed higher values 
in the former. 
tRNA adenine I-methyltransferase [EC 2.1.1.36] 
(tRNA-AMT) is an enzyme or group of closely related 
enzymes that methylates the 1 position of adenine 
residues in a tRNA polynucleotide chain. Unlike the 
recently reported non-specific RNA adenine- 1- 
methyltransferase extracted from the nuclear fraction 
of the dinoflagellate Cripthecodinium cohnii (WERNER 
et al . ,  1976). tRNA-AMT seems to  recognize specific 
sequences within the tRNA molecule for the insertion 
of the methyl group (KUCHINO & NISHIMURA. 1974). 
In the past years several attempts have been made 
to  purify this enzyme using biological material from 
different sources (e.g. rat liver, HeLa cells and pro- 
karyotic cells) (BAGULEY & STAEHELIN, 1968~1,b; 
KUCHINO & NISHIMURA, 1970; AGRIS ef a!., 1974; 
KERR, 1974; CLICK et al., 1975). The activity was 
shown to be affected by polyamines, divalent cations, 
ammonium acetate. SAM and SAH (YOUNG & SRINI- 
VASAN, 1971; PEGG, 1971; HACKER, 1973; LEBOY & 
GLICK, 1976). In a previous study we reported a rela- 
tive decrease in the methylation of E. col i  bulk tRNA 
adenine residues when 2.5 mM-spermidine was present 
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S-adenosyl-r-homocysteine: SAC. S-adenosyl-L-cysteine: 
SADH. S-adenosyl-o-homocysteine; 
in the incubation mixture containing a crude enzyme 
preparation from rat brain cortex (SALAS et a/., 1976). 
At least two possibilities were suggested to  explain 
the observed results: (a) spermidine inhibits the 
methylation of adenine residues in position 1 ; or (b) 
the methylation of all other bases is proportionately 
higher than that of adenine in position 1, a n d  this 
is reflected in an apparent, relative decrease in  the 
percentage of I-methyladenine formed. The same 
study (SALAS et a/., 1976) also showed a relative 
enrichment in tRNA-AMT activity in extracts derived 
from bulk-isolated nerve cell bodies (SELLINGER et a/., 
1971) as  compared to  similar preparations obtained 
from the brain cortex (neurons + glial cells). To clar- 
ify some of these issues, we decided t o  examine the 
cellular localization of tRNA-AMT and compare 
some of the properties of the partially purified enzyme 




S-Adenosyl-t-[methyl 14C]methionine (specific activity 
45 mCi/mmol) was purchased from Research Products In- 
ternational (Elk Grove Village, IL); €. coli bulk tRNA 
from Schwartz-Mann (Orangeburg, NY): E. coli tRNAPhr 
and E. coli tRNA'"' from Miles Laboratories (Elkhart, IN); 
E. coli tRNAe'"' and S-adenosyl-t-methionine from 
Boehringer Mannheim (Indianapolis, IN). The methylated 
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bases used as  standards were from Sigma Chemical Com- 
pany (St. Louis. MO): PBondapak C I B  columns (30 x 0.4 
LD. cm) lrom Waters Associates, Inc. (Milford. MA); tri- 
Ruoroacetic acid from Matheson, Coleman and Bell (East 
Rutherford. NJ);  ammonium phosphate monobasic from 
J. J. Baker (Phillipsburg. NJ): spheroidal hydroxylapatite 
from Gallard-Schlesingrr (Carle Place. NY); S-adenosyl-L- 
homocysteine and its analogs from Sefochem Fine Chemi- 
cals (Jordan Valley. Israel). Spermidine phosphate was 
from Sigma Chemical t o .  (St. Louis, MO). putrescine 
dihydrochloride and spermine tetrahydrochloride were 
from Mann Research Laboratories (New York, NY). 
Apparatus 
A solvent delivery system equipped with a dual piston 
pump. model 6000A. a universal liquid chromatography 
injector model U6K and an absorbance detector model 
440 were from Waters Associates. Inc. (Milford, MA). The 
chromatographic run was recorded on an Omniscribe 
recorder, Texas Instruments (Austin. TX). 
Methods 
Hjdrulysis of [merhyl- I4C] c R N A .  Trifluoroacetic acid 
(I"ml) was added to [methyl-'4C]tRNA in a combustion 
tube (25 x 2.0 1.D. cm) (A. H. Thomas Co.. Philadelphia, 
PA) sealed under vacuum and incubated at 170°C for 
30 min. After hydrolysis the trifluoroacetic acid was eva- 
porated under a stream of N, a t  room temperature and 
the dry residue stored at 4'C. 
Chromarographic analysis. The tRNA hydrolysate (SALAS 
er al.. 1976) containing between 2000 and 1O.OOO dpm was 
dissolved in water (0.2 ml) and applied to the column via 
the injector septum at room temperature using a 100jd 
syringe (Precision Sampling Corp., Baton Rouge, LA). 
After sample injection the flow rate was maintained at 
2 ml/min. For optimal separation (SALAS & SELLINGER. 
1977) of the [methyl-'"C] bases in the hydrolysate, buffer 
solutions were changed 350 s after injection. Fractions 
(0.0241 ml) were collected in plastic mini-vials (Rochester 
Scientific Co., Inc., Rochester. NY) to which 2 ml of tissue 
solubilizer-scintillation mixture was added (Amersham, 
Searle. Arlington Heights, IL). The radioactivity of the 
samples was determined in a Beckman 250 liquid scintilla- 
tion spectrometer. All buffers and samples were filtered 
through Millipore filters (0.45pm pore size) and were 
degassed in uacuo prior to use. 
Merhylation of E. coli rRNA in vitro. Both the 'rate' 
and 'extent' methylation assay mixtures (PECG, 1971) as  
applied to brain tissue have been described elsewhere 
(SAUS e f  aJ.. 1976). For the study of the kinetic parameters 
and of the effects of SAH analogs on enzyme activity the 
assays were performed in the 'rate' mode. 
Prrpararion of rRNA-AMT Male. Sprague-Dawley rats 
(8 days-old) were decapitated and the brain cortices 
(approx 15g) quickly removed and homogenized in a 
glass-Teflon Potter-Elvehjem homogenizer to a final 
volume of 3.5 times the tissue weight. The buffer solution 
contained 10 mM-Tris-HCI pH 7.6, 1 mM-EDTA and 
I mwdithiothreitol (DIT). The homogenate was centri- 
fuged at 165,OOOg for 150min and the clear supernatant 
fractionated with a saturated solution of ammonium sul- 
fate at pH 7.0 (PECG, 1971). The final pellet was recovered 
by centrifugation. resuspended in 10 mM-Tris-HCI buffer 
pH8.0, containing I mM-EDTA and 1 mM-DTT (buffer A) 
and was dialyzed overnight against 3 1 of the same buffer. 
The dialysis residue (ca. 10ml) was then made 1 mM in 
Na phosphate and applied to a column (25 x 1.5cm) of 
spheroidal hydroxylapatite, previously equilibrated with 
the same buffer. The column was then washed with a 
volume of buffer. equivalent t o  that of the sample, follow- 
ing which a linear gradient of Na phosphate ( 1 4 0 0 m ~ ;  
300ml) in buffer A was used to elute the enzyme. The 
total tRNA methyltransrerase activity in the eluates was 
determined using E. culi bulk tRNA as methyl acceptor. 
Peak 1 (Fig. IA)  was pooled and concentrated by precipi- 
tation with solid ammonium sulfate to 80% saturation. The 
precipitate was collected by centrifugation and dissolved 
in 2.0 ml of 50 mM-Tris, pH 8.0 containing 0.1 mM-EDTA 
and I mM-DTT and was dialyzed overnight against 2 1 of 
the same buffer. The non-diffusible material was applied 
to a column ( I  30 x 0.9 cm) of Sephadex G-200 previously 
equilibrated with the 50 mM-Tris buffer. Enzyme activity 
was eluted using the same Tris buffer and fractions were 
pooled and concentrated by solid ammonium sulfate preci- 
pitation (80%). The precipitate obtained after centrifuga- 
tion was dissolved in a small volume of buffer A. Measured 
aliquots of the enzyme were stored a t  -70°C. 
r R N A - A M T  from npuronal cell bodies. Neuronal cell 
bodies. prepared from cerebral cortices of 8 day-old male 
rats as previously described (SELLINGER ef a/., 1971 ; SELL- 
INGER & AZCURRA. 1974) were suspended and homogen- 
ized in the same buffer used for whole cortices (3.5ml/g 
Fraction Number 
FIG. 1. Spheroidal hydroxylapatite chromatography of rat 
brain tRNA methyltransferases. The column was eluted 
with a linear 1400 mM-Na phosphate gradient. Aliquots 
(250 PI) were analyzed for tRNA methyltransferase activity 
in the 'rate' mode (PEGG, 1971). (A) whole brain cortex 
tRNA methyltransferases. (B) neuronal tRNA methyltrans- 
ferases. For details see Methods. 
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FIG. 2. Chromatography of tRNA-AMT from whole rat 
brain cortex on Sephadex (3-200. Aliquots (250pl) were 
tested for tRNA-AMT activity in the ‘rate’ mode. For 
details, see Methods. 
of neuronal pellet). Subsequent treatment of this prep- 
aration was identical to that described for the cortical 
enzyme. 
Protein defermindon. Protein was determined according 
to LOWRY et al. (1951). using crystalline bovine serum albu- 
min as standard. 
RESULTS 
Spheroidal hydroxylapatite chromatography 
resolved two peaks of methyltransferase activity, as 
shown in Fig. IA. The first peak contained most of 
the tRNA-AMT, while the second peak contained 
some tRNA-AMT + significant tRNA-guanine NZ-  
methyltransferase and tRNA-guanine-Ni-dimethyl- 
transferase activity. In contrast, equivalent prep- 
arations derived from cortical neuronal cell bodies 
contained virtually only tRNA-AMT enzyme activity, 
as shown in Fig. 1B. It should be noted that the elu- 
tion volumes for the first peak in Figs. 1A and 1B 
were the same regardless of the source of the enzyme. 
Also, the ammonium sulfate precipitation and dialysis 
steps prior to chromatography were found to be 
essential for the successful separation of tRNA-AMT 
from the other tRNA-methylating activities. 
Peak 1 (Fig. 1A) was further purified by passage 
through a column of Sephadex G-200 (Fig. 2). The 
effluent fractions containing tRNA-AMT activity 
were treated as described in Methods and were stored 
at -70°C for up to 6 months without detectable loss 
of activity. 
To determine the methyl base specificity of tRNA- 
AMT unequivocally, bulk E .  coli tRNA was methyl- 
ated using enzyme preparations partially purified 
through the hydroxylapatite and/or Sephadex G-200 
steps. The resulting [methyl-L4C]tRNA was hyro- 
lyzed with trifluoroacetic acid at 170°C for 30min 
and following the evaporation of the acid, the hydro- 
lyzates were subjected to  high performance liquid 
chromatography (HPLC) as described in Methods 
(SALAS & SELLINGER, 1977). The radiometric analysis 
of the HPLC eluates revealed that virtually all of the 
radioactivity was confined to the elution position cor- 
responding to 1 methyladenine (Fig. 3). Separate 
methylation assays using cortical enzyme prep  
arations revealed, in addition to [methyl- “Cll- 
methyladenine. residual amounts of [methyl- L4C]l- 
methylguanine and Nz-methylguanine. both repre- 
senting no more than 10% of the total [methyl-“’C]- 
tRNA formed. Table 1 summarizes the purification 
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FIG. 3. High performance liquid chromatography (HPLC) of E. coli [methyl ~ “]tRNA hydrolyates 
on jiBondapak CIg .  The enzyme activity was measured in the ’extent’ mode (PEGG, 19711. For details. 
see Methods. 
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TABLL 1. PURIFICATION OF tRNA-AMT FROM RAT BRAIN CORTEX' 
Vol. Protein Units/mg Yield 
Fraction (ml) Unitst/ml Total units (mg/ml) protein (%) x-fold 
Homogenate 52 61,534 3.2 x lo6 19.8 528 100 0 
High speed 
Ammonium 
supernatant 48 41.665 2.0 x 106 6.7 I057 62.5 2.0 
1118 40.6 2.1 sulfate ppt. 13 99,995 1.3 x 10' 15.2 
11.3 12,200 12.9 23.1 Hydroxylapatite 3 137,852 4.1 105 
Sephadex G-200 3 11,360 5.7 x 104 0.27 42,074 1.8 79.7 
14.4 g of tissue 
t D.p.m. [methyl- tRNA/30 min. 
Comparing the effects of NH: and Mgz+ revealed 
a range of concentrations over which the activity of 
both the cortical and neuronal tRNA-AMT failed to 
change much. The range was 3 - 7 m ~  for Mg" and 
0.2-0.8 M for NH;. Using 100 mM-Tris buffer. maxi- 
mal tRNA-AMT activity was found between 
The findings shown below are from experiments in 
which we used tRNA-AMT from whole brain cortex 
(unless otherwise stated); the enzyme derived from 
nerve cell bodies yielded analogous results. Figure 4 
is a comparative study of the effect of different con- 
centrations of spermidine, spermine and putrescine on 
whole cortex tRNA-AMT. Spermidine produced a 
maximal stimulatory effect at 2-3 mM, as previously 
demonstrated for the unfractionated brain cortex 
tRNA methyltransferases (SALAS et al., 1976). Alterna- 
tively, I-mht-spermine and 4(Mo m-putrescine were 
the most suitable concentrations to produce maximal 
tRNA-AMT activity. In another experiment the kin- 
etic parameters for tRNA-AMT were examined and 
an apparent K ,  of 6 p ~  determined for SAM. The 
methylation of tRNA was competitively inhibited by 
SAH with a K i  of 3 . 4 ~ ~ .  
Table 2 lists the effect of a number of SAH analogs 
on the activity of the neuronal tRNA-AMT. Of all 
compounds tested, the strongest inhibitory effect was 
pH 8.2-8.4. 
produced by ( W 4 ~ )  S-adenosyl-L-cysteine (SAC) 
(35%), while a weaker effect was observed with 
(1 0 - 4 ~ )  S-adenosyl-o-homocysteine (SADH) (21 %). 
A further characterization of tRNA-AMT was un- 
dertaken using individual E. coli tRNA species as sub- 
strates. As shown in Table 3, the extent methylation 
of the various E. coli tRNAs varied markedly, that 
of tRNAs'"z being the most and that of tRNAph' being 
the least effective. The extent methylations of tRNAPhe 
and tRNA'"' were equivalent to 12% and 20% respect- 
ively, of that noted with tRNAgl"*, in good agreement 
with similar values obtained using rat liver tRNA- 
AMT (KUCHINO & NISHIMURA, 1974; CLICK et al., 
1975). 
To determine the cellular distribution of tRNA- 
AMT, fractions of equivalent purity were prepared 
from whole cerebral cortex, bulk-isolated neuronal 
cell bodies and glial cells (SELLINGER et al., 1971) and 
cultured astrocytes derived by growing 3-day old 
whole rat brain cortex in primary culture for 12-14 
days (CUMMINS& GLOVER, in press). Table 4 shows that 
[methyl-'4C] I-methyladenine represented 41.5% of 
the total radioactivity recovered after HPLC in the 
neurons as against 30.2% and 28.1% in the two types 
of glial cells, with an intermediate 32.1% in the whole 
cortex. Conversely N2-methylguanine formation 
(SALAS et al., 1977) was significantly higher in both 
spumidin,mM -in, mM pumrckr.mY 
FIG. 4. Effect of polyamines on tRNA-AMT activity using bulk E.  coli tRNA. The enzyme activity 
was measured in the 'rate' mode using cortical tRNA-AMT. 
Cerebral tRNA adenine-I -methyltransferase 89 
TABLE 2. THE INHIBITION OF BRAIN tRNA-AMT 
% Inhibition 
Compound 1 0 - 4 ~  1 0 - 5 ~  lo-% 
S- Adenosyl-L-homocysteine 84 34 2.2 
S- Adenosyl-D-homocysteine 21 12 2.2 
S- Adenosyl-L-cysteine 35 0 0 
S-5'-Butyl-5'-deoxyadenosine 0 0 0 
S-Adenosyl-5-deoxy-5'-thioethanol 0 0 0 
S-5'-lsobutyl-5'-deoxyadenosine 0 0 0 
2-0-Methyladenosine 0 0 0 
9-fi-D-Arabinofuranosyladenosine 0 0 0 
9-fi-~-Arabinofuranosylhypoxanthine 0 0 0 
I -fi-D-ArabinofuranosyluraciI 0 0 0 
Adenosine I I  0 0 
Neuronal cells from 8-day old rat cerebral cortex were used as the source of the enzyme. 
tRNA-AMT was incubated in the presence of E. coli tRNA, 2.5 mM-spermidine and S-adeno- 
syl-~-[methyl-'*C]rnethionine for 30 min at 37°C. followed by 10% cold TCA precipitation. 
Radioactivity was recovered on Millipore filters (see Methods). 
bulk-isolated (42.2%) and  cultured (34.1 %) glial cells TABLE 3. METHYLATION OF INDIVIDUAL E.  
than in the neuronal cell bodies (18.2%). coli tRNA SPECIES 
tRNA Relative activity 
DISCUSSION 
Bulk 1.00 
A procedure is described which yields an 80-fold 
purified tRNA-AMT, essentially free of contaminating 
guanine-specific tRNA methyltransferases, from the 
8-day old rat cerebral cortex and  its neurons. The 
procedure requires relatively small amounts  of tissue 
(ca. I5g). It is of interest that a much higher degree 
of purification and  hence a much more laborious pro- 
cedure was found necessary t o  free tRNA-AMT of 
rat liver (GLICK et al., 1975) and of HeLa cells (AGRIS 
et al., 1974) of contaminating tRNA methyltransfer- 
ases. N o  differences were detected in the present study 
between the tRNA-AMT purified from the whole cor- 








Enzymes were from 8-day old rat cerebral 
cortex. 'Extent' assay was performed in the 
presence of 2.5 mM-spermidine, I mg of brain 
protein and tRNA between 1.5 and 20 nmol. 
Incubation: 2 h. 
'Activity with bulk tRNA: 6.3 x lo4 
d.p.m./mg/l20 min. 
T h e  study of tRNA-AMT inhibitors (Table 2) 
demonstrated that 10-4~-SAH inhibited tRNA-AMT 
almost totally while IO+'M-SAH failed t o  inhibit the 
enzyme. Inhibition by 1 0 - 4 ~ - S A D H  and SAC was 
TABLE 4. A COMPARISON OF tRNA METHYLTRANSFERASE METHYLATING CAPACITY IN CEREBRAL CORTEX. 
BULK-ISOLATED CORTICAL NEURONS AND GLIAL CELLS AND CULTURED ASTROCYTES' 
Bulk-isolatedt 
[Methyl-14C] Base 
Neuronal Glial Cultured 









































* Values are expressed as 7, of total recovered radioactivity after HPLC wt to 100%. The actual 
recovery of d.p.m. among the methylated bases as % of the d.p.m. injected into the HPLC machine 
was above 907; in most cases and approached 95% in some. tRNA methyltransferases: ammonium 
sulfate precipitate (0-80%) of the 165.ooO g/lSO min supernatant obtained from the homogenate of 
the indicated tissue or cell source. N.D. Not detected. 
t B y  the procedure of SELLINGER ef a/. (1971): :By the procedure of CL:MMINS & GLOVER (1978). 
'Extent' assay. 2 h. Spermidine: 2 . 5 m ~ :  Substrate: E. coli tRNA (bulk). IOpg. 
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35", and ?lo, respectively, indicating a lower effec- 
tiveness of these analogs, when compared to SAH 
(HILDESHEIM et al.. 1973a. h ;  TREWYN & KERR, 1976). 
Comparing the inhibitions by SAC and SADH 
revealed that the length of the amino acid chain is 
not a critical factor determining their efficacy as 
tRNA-AMT inhibitors and that IO-'M-SADH is 
slightly more effective than 10-S~-SAC. 
The concentration of NH: necessary for maximal 
stimulation of brain tRNA-AMT was higher than that 
(0.1-0.25 M) previously reported for both non-neural 
(PEGG. 1971 ; YOUNG & SRINIVASAN, 1971 ; HANCEK 
& ELEFTHERIOU, 1971) and neural (HANCOCK & ELEF- 
THERIOU. 1971) tRNA methyltransferases and, more 
recently, by LEBOY & GLICK (1976) for the highly 
purified rat liver tRNA-AMT. The rat brain tRNA- 
AMT also appeared to differ from the purified rat 
liver enzyme (LEBOY & GLICK, 1976) in terms of its 
Mgz+ requirements, since appreciable activity was 
determined in the presence of 2-10mM-Mg2+ with 
no polyamines or NH: co-present, whereas LEBOY 
& GLICK (1976) reported negligible activity in the 
presence of 0.5-10 mM-Mg", when compared to the 
activity measurable in the presence of optimal NH; 
concentrations. Alternatively, comparing the total 
d.p.m. incorporated into tRNA (Figs. 4A-C), reveals 
that putrescine (Fig. 4C) produced the maximal sti- 
mulatory effect. 
The in uirro stimulation of tRNA methyltransfer- 
ases by spermine. spermidine and putrescine (Fig. 5) 
is a well documented phenomenon (PEGG, 1971; 
YOUNG & SRINIVASAN, 1971; HACKER, 1973; LEBOY 
& PESTER, 1973; CUMMINS et al., 1975; SALAS et al., 
1976, 1977; DAINAT et al.. 1977). It is of interest to 
note, however, that while spermine affected brain 
tRNA-AMT and non-neural tRNA methyltransfer- 
ases optimally at  approx 1-1.5mM (PEGG, 1971; 
YOUNG & SRINIVASAN, 1971; HACKER et al., 1973), 
spermidine and putrescine affected brain tRNA-AMT 
and non-neural tRNA methyltransferases differently. 
For example, PEGG (I97 1) found maximal stimulation 
of rat liver tRNA methyltransferases by 15-25m~-  
putrescine, while brain tRNA-AMT (Fig. 4) required 
40-60 mwputrescine for optimal activity, a value 
which compared favorably with the values of 60 mM 
and W 5 0 r n ~  found optimal for the tRNA methyl- 
transferases of leukemic cells (HACKER, 1973) and 
purified rat liver tRNA-AMT (LEBOY & GLICK, 1976). 
Our  results also show (Fig. 4) that. like the rat liver 
tRNA methyltransferases (PEGG, 1971; YOUNG & 
SRINIVASAN, 1971). brain tRNA-AMT required 
2-3 mM-spermidine, whereas the purified liver tRNA- 
AMT (LEBOY & GLICK, 1976) was maximally stimu- 
lated by 12-14 mM-spermidhe. It is of further interest 
that HACKER (1973) noted two spermidine concen- 
tration optima for the tRNA methyltransferases of the 
leukemic cells, one a t  3 and the other at approx 
10 mM. Although the ranking of the polyamines' effec- 
tiveness as stimulators of cerebral tRNA-AMT agrees 
with the accepted notion that putrescine is the most 
effective polyamine (HACKER, 1973). MOLLER er al. 
(1977) recently showed lOm~-spermine to be most 
effective in stimulating tRNA methylation by adult 
rat brain extracts and 20 mwspermidine to be most 
effective with the fetal and the newborn rat brain 
enzymes. 
When tRNA-AMT was tested with different indivi- 
dual E. coli tRNA species (Table 3), tRNAg'"' and 
tRNAph' proved to be the best and the least effective 
substrates, respectively. These results are in complete 
accord with the findings of KUCHINO & NISHIMURA 
(1974) and of GLICK et al. (1975) who used adult rat 
liver tRNA-AMT. Examining the methylation of 
tRNA'"" by tRNA methyltransferases of the imma- 
ture (6 days) and weanling (21 days) rat cerebellum 
(DAINAT et a/., 1977, and unpublished observations) 
we recently noted that in the 6-day old animal 
1-methyl-adenine formation failed to exceed 10% of 
the total methylated bases formed, while at 21 days 
it rose to approx 38% in the absence of spermidine, 
being virtually nil in its presence. These findings sug- 
gest a finely tuned and developmentally controlled 
sensitivity of this reaction toward polyamines. 
The results shown in Table 4 demonstrate that 
neurons contain appreciable levels of tRNA-AMT ac- 
tivity, in confirmation of our previous circumstantial 
findings (SALAS et a/., 1976). To find out whether 
tRNA-AMT is selectiuely enriched in neurons, we pre- 
pared tRNA-AMT-containing fractions from bulk- 
isolated and cultured glial cells and compared them 
to equivalent cortical and neuronal fractions. The 
results indicate that, although both glial preparations 
contained tRNA-AMT activity, the per cent contribu- 
tion of [methyl-14C]1-methyladenine to the total 
methylated bases was significantly lower in the glial 
cells than in the whole cortex or the neurons. On 
the premise that the content in tRNA-AMT of each 
isolated cell type reflects the in uiuo situation. neurons 
are therefore a relatively richer source of tRNA-AMT 
than are glial cells. Whether the neuronal and the 
glial tRNA-AMT activities have different site specifi- 
cities, as do the enzymes of Phaseolus uulgaris (DUBOIS 
et al., 1974), and whether the enrichment of tRNA- 
AMT in nerve cells has a functional correlate, i.e. the 
control of the synthesis of neuron-specific proteins 
remains to be established. 
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